U.S., Feb. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07392476) titled 'Continuous Glucose Monitoring in Polycystic Ovarian Syndrome' on Dec. 29, 2025.
Brief Summary: The purpose of this study is to learn more about blood sugar control in polycystic ovarian syndrome.
The patient will be asked to wear a continuous glucose monitor (CGM) device that is applied to the arm with a sensor or filament that goes under the skin to measure your sugar levels. The patient will wear this at certain time points throughout the study. There will have a total of 2 blood draws (about 1 tsp. of blood) at screening and the 6-month visit, a measure of the patients body muscle and fat (body composition), and fill out a questi...